What is the current Price Target for the InMed Pharmaceuticals Inc stock?

The average InMed Pharmaceuticals Inc target price is $20.40. This is 844.44% higher than the current stock price. The highest price target is 872.22%, the lowest is 835.19%. 2 Analysts have issued a price target InMed Pharmaceuticals Inc 2026 .

How high will the InMed Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the InMed Pharmaceuticals Inc stock will rise. The performance of stocks, including the InMed Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the InMed Pharmaceuticals Inc stock today?

The performance of InMed Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the InMed Pharmaceuticals Inc stock fall?

The decline in InMed Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

InMed Pharmaceuticals Inc Forecast, price target & analysts

$2.16

0.47% yesterday

Nasdaq, Oct 21, 10:00 pm CET

ISIN

CA4576375022

Symbol

INM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

InMed Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

InMed Pharmaceuticals Inc Classifications & Recommendation:

Hold

38%

Sell

63%

InMed Pharmaceuticals Inc Price Target

Target Price	$20.40
Price	$2.16
Potential	844.44% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target InMed Pharmaceuticals Inc 2026 . The average InMed Pharmaceuticals Inc target price is $20.40. This is 844.44% register free of charge higher than the current stock price. The highest price target is $21.00 872.22% register free of charge , the lowest is $20.20 835.19% register free of charge .
	A rating was issued by 8 analysts: 0 Analysts recommend InMed Pharmaceuticals Inc to buy, 3 to hold and 5 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the InMed Pharmaceuticals Inc stock has an average upside potential 2026 of 844.44% register free of charge . Most analysts recommend the InMed Pharmaceuticals Inc stock at Sale.

Discover more stocks with a high price target

TUI 49.08%

BYD 30.92%

BioNTech SE - ADR 30.73%

Deutsche Telekom 29.33%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today